Bayer Has Agreed to Settle Yaz Lawsuits Brought by 70 People: Report

Bayer Healthcare reports that it has reached agreements to settle Yaz and Yasmin lawsuits brought by at least 70 women, but continues to face about 11,300 additional claims by women who have suffered serious, and sometimes fatal injuries, allegedly caused by their popular birth control pills.

In the legal risks section of their 2011 Annual Financial Report, Bayer outlines the status of the Yaz litigation for investors and indicates for the first time that some settlements have been reached.

Although details about the Yaz settlements has not been disclosed, Bayer did indicate that they are continuing to consider settling lawsuits on a case-by-case basis.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

Thousands of women throughout the United States are pursuing financial compensation from Bayer through a Yaz lawsuit or Yasmin lawsuit, alleging that the drug maker failed to adequately warn about the increased risk of blood clots and other serious injuries.

The claims center on the side effects of drospirenone, a newer type of progestin that is used in the oral contraceptives in combination with estrogen. It was first introduced in Yasmin birth control by Berlex Laboratories, which was later acquired by Bayer. Yaz is an updated version of the birth control pill, and Bayer recently introduced a third variation, marketed as Beyaz, which also includes a folate supplement.

Several studies have suggested that women taking Yaz or other drospirenone-based birth control pills face an increased risk of blood clots, stroke, pulmonary embolism, deep vein thrombosis and sudden death.

Last year, the FDA released a report that suggested drospirenone birth control pills may increase the risk of blood clots by 75% over older pills. They also doubled the risk of heart attacks and strokes in users who were now to birth control, with some health problems appearing in less than three months after women started using the pills.

Earlier this year, the federal judge presiding over all lawsuits filed in U.S. District Courts throughout the United States ordered Bayer and plaintiffs’ lawyers to engage in Yaz settlement negotiations before the first cases are submitted to a jury. Known as bellwethers, those early trial dates are often used to facilitate discussions to settle other lawsuits, and may help the parties gauge how juries are likely to respond to evidence that is likely to be introduced in multiple cases.

Generic versions of Yaz and Yasmin are also now available from other manufacturers, including Ocella, Gianvi, Loryna, Safyral, Syeda and Zarah.

Image Credit: |

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Johnson & Johnson Faces Medical Monitoring Lawsuit Over Future Baby Powder Cancer Risks
Johnson & Johnson Faces Medical Monitoring Lawsuit Over Future Baby Powder Cancer Risks (Posted yesterday)

Women who used Johnson's Baby Powder around their genitals for feminine hygiene purposes now live in fear of developing ovarian cancer, according to the class action lawsuit seeking medical monitoring for future diagnoses

More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing
More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing (Posted 2 days ago)

A bundled complaint of about 9,600 Suboxone lawsuits were filed in federal court on Friday, ahead of the two-year anniversary of the FDA requiring tooth decay label warnings on the opioid treatment film strips, which is also a deadline for filing a civil complaint in many states.